drugset / Trial / NCT00746772

Efficacy of Purslane in Treatment of Oral Lichen Planus

NCT00746772 ↗

Phase 2 Completed 37 enrolled Qazvin University Of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Oral lichen planus (OLP) is a chronic inflammatory disease whose prevalence in the general population is 0.5 -2.2%.Oral lesions in OLP are chronic, rarely undergo spontaneous remission. Patients with OLP had significantly increased risk of oral squamous cell carcinoma, irrespective of the clinical type of OLP and therapy. there is currently no cure for OLP. Previous study demonstrated a decreased antioxidant defence and increased oxidative damage to lipids.DNA and proteins in lichen planus. This oxidative modifications point to pathophysiological alterations mainly within the basal cell layers of epidermis and at the dermoepidermal junction. Purslane is an excellent source of vitamin A,C and E and essential amino acids, has been described as a power food of the future because of its high nutritive and antioxidant properties. The purpose of the study was to determined the efficacy of Purslane in the treatment of oral lichen planus.

Timeline

Start
2006-04
Primary completion
2008-05
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Purslane Unknown 235 mg —

Indications